Where Does Brickell Biotech Inc (BBI) Stock Fall in the Biotechnology Field After It Is Up 6.47% This Week?

Wednesday, August 03, 2022 01:52 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Brickell Biotech Inc (BBI) Stock Fall in the Biotechnology Field After It Is Up 6.47% This Week?

The 62 rating InvestorsObserver gives to Brickell Biotech Inc (BBI) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 71 percent of stocks in the Biotechnology industry, BBI’s 62 overall rating means the stock scores better than 62 percent of all stocks.

BBI has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on BBI!

See Full BBI Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 62 means the stock is more attractive than 62 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Brickell Biotech Inc Stock Today?

Brickell Biotech Inc (BBI) stock is trading at $3.29 as of 1:46 PM on Wednesday, Aug 3, a rise of $0.14, or 4.44% from the previous closing price of $3.15. The stock has traded between $3.15 and $3.45 so far today. Volume today is light. So far 116,511 shares have traded compared to average volume of 368,604 shares. Click Here to get the full Stock Report for Brickell Biotech Inc stock.